设为首页
收藏本站
网站地图
|
English
|
公务邮箱
About the library
Background
History
Leadership
Organization
Readers' Guide
Opening Hours
Collections
Help Via Email
Publications
Electronic Information Resources
常用资源
电子图书
期刊论文
学位会议
外文资源
特色专题
内部出版物
Wiley电子期刊(41)
SpringerLink电子期刊(2489)
Elsevier电子期刊(1977)
Springer电子图书(10)
NATURE电子期刊(11)
ACS电子期刊(18)
在“
SpringerLink电子期刊
”中,
命中:
2,489
条,耗时:小于0.01 秒
在所有数据库中总计命中:
4,546
条
1.
Long-term survival in advanced non-squamous NSCLC patients treated with first-line
bevacizumab
-based therapy
作者:
J. De Castro
;
J. L. González-Larriba
;
S. Vázquez…
关键词:
Non
;
squamous NSCLC
;
First
;
line treatment
;
Bevacizumab
;
Bevacizumab
maintenance therapy
;
Routine clinical practice setting
;
Observational study
刊名:Clinical and Translational Oncology
出版年:2017
2.
Toxicity profile of
bevacizumab
in the UK Neurofibromatosis type 2 cohort
作者:
Katrina A. Morris
;
John F. Golding
;
Claire Blesing…
关键词:
Neurofibromatosis type 2
;
Cardiac failure
;
Bevacizumab
;
Hypertension
;
Proteinuria
;
Toxicity
刊名:Journal of Neuro-Oncology
出版年:2017
3.
Early perfusion MRI predicts survival outcome in patients with recurrent glioblastoma treated with
bevacizumab
and carboplatin
作者:
Iwan E. Bennett
;
Kathryn M. Field
;
Christopher M. Hovens…
关键词:
Bevacizumab
;
Glioblastoma
;
DSC
;
MRI
;
rCBV
;
Perfusion
刊名:Journal of Neuro-Oncology
出版年:2017
4.
Alisertib demonstrates significant antitumor activity in
bevacizumab
resistant, patient derived orthotopic models of glioblastoma
作者:
C. Kurokawa
;
H. Geekiyanage
;
C. Allen
;
I. Iankov
;
M. Schroeder…
关键词:
Aurora A
;
Alisertib
;
GBM
;
Bevacizumab
;
Resistance
刊名:Journal of Neuro-Oncology
出版年:2017
5.
Subfoveal choroidal thickness changes after intravitreal
bevacizumab
injection for neovascular age-related macular degeneration and diabetic macular edema
作者:
Cihan Ünlü
;
Gurkan Erdogan
;
Betul Onal Gunay
;
Esra Kardes…
关键词:
Choroidal thickness
;
Diabetic macular edema
;
Enhanced depth imaging
;
Intravitreal
bevacizumab
;
Neovascular AMD
;
Optical coherence tomography
刊名:International Ophthalmology
出版年:2017
6.
The brain-penetrating CXCR4 antagonist, PRX177561, increases the antitumor effects of
bevacizumab
and sunitinib in preclinical models of human glioblastoma
作者:
Giovanni Luca Gravina
;
Andrea Mancini…
关键词:
Glioblastoma
;
CXCR4
;
Bevacizumab
;
Sunitinib
刊名:Journal of Hematology & Oncology
出版年:2017
7.
Retrospective study of
RAS/PIK3CA/BRAF
tumor mutations as predictors of response to first-line chemotherapy with
bevacizumab
in metastatic colorectal cancer patients
作者:
Izuma Nakayama
;
Eiji Shinozaki
;
Tomohiro Matsushima
;
Takeru Wakatsuki…
关键词:
RAS mutation
;
PIK3CA mutation
;
BRAF mutation
;
Colorectal cancer
;
bevacizumab
刊名:BMC Cancer
出版年:2017
8.
A phase I study of afatinib combined with paclitaxel and
bevacizumab
in patients with advanced solid tumors
作者:
James Spicer
;
Sheeba Irshad
;
Joo Ern Ang…
关键词:
Afatinib
;
Paclitaxel
;
Bevacizumab
;
Phase I
;
Solid tumors
刊名:Cancer Chemotherapy and Pharmacology
出版年:2017
9.
[18F]FDG PET/CT-based response assessment of stage IV non-small cell lung cancer treated with paclitaxel-carboplatin-
bevacizumab
with or without nitroglycerin patches
作者:
Evelyn E. C. de Jong
;
Wouter van Elmpt…
关键词:
[18F]FDG PET/CT
;
Response assessment
;
Nitroglycerin
;
Bevacizumab
;
Stage IV NSCLC
刊名:European Journal of Nuclear Medicine and Molecular Imaging
出版年:2017
10.
Efficacy and safety of re-induction therapy with
bevacizumab
and paclitaxel for metastatic breast cancer
作者:
Tetsuhiro Yoshinami
;
Toshinari Yagi
;
Jun Okuno
;
Nobuyoshi Kittaka…
关键词:
Metastatic breast cancer
;
Bevacizumab
with paclitaxel
;
Re
;
induction therapy
刊名:Breast Cancer
出版年:2017
1
2
3
4
5
6
7
8
9
按检索点细分(2489)
题名(1760)
作者(3)
关键词(959)
文摘(1352)
按出版年细分(2489)
2017年(31)
2016年(215)
2015年(366)
2014年(313)
2013年(303)
2012年(282)
2011年(181)
2010年(199)
2009年(194)
2008年(187)
2007年(124)
2006年(58)
2005年(25)
2004年(8)
2002年(3)
NGLC 2004-2010.National Geological Library of China All Rights Reserved.
Add:29 Xueyuan Rd,Haidian District,Beijing,PRC. Mail Add: 8324 mailbox 100083
For exchange or info please contact us via
email
.